According to the latest report by IMARC Group, titled “GCC Intravenous Solutions Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the GCC intravenous solutions market size reached US$ 701.5 Million in 2022. Intravenous solutions, commonly referred to as IV fluids, are essential components of patient care, particularly in hospital settings. They are fluids intended to be administered into the venous circulation directly to provide hydration, nutrition, or medication to patients who cannot ingest substances orally or require immediate therapeutic intervention. Intravenous solutions come with distinct characteristics based on their composition. They can be categorized into two main types: crystalloids and colloids. Crystalloids, like saline or dextrose water, contain substances that quickly dissolve into solution. Colloids contain larger insoluble molecules, such as gelatin, and are used to increase the volume of fluid in the blood vessels rapidly. In terms of features, IV fluids offer several benefits. They provide a direct and controlled method of administration, enabling rapid response to critical situations. This immediacy makes them indispensable in cases of severe dehydration, electrolyte imbalances, during surgeries, and for medication delivery. The composition of intravenous solutions can be adjusted according to the specific needs of the patient. Additionally, these solutions can be supplemented with vitamins, minerals, and trace elements to meet the nutritional needs of patients who cannot eat or absorb nutrients from the gastrointestinal tract. Furthermore, specialized intravenous solutions like blood products and biologics have a significant role in treating various conditions.
GCC Intravenous Solutions Market Trends:
The rise in the incidence of chronic diseases, such as diabetes, cancer, and cardiovascular diseases, represents one of the key factors driving the market growth of intravenous solutions across the GCC region. This, coupled with the increased need for elderly care in the GCC region, is catalyzing the demand for intravenous solutions. Additionally, the rising emphasis on adequate hydration and nutrition in hospitals and clinical settings is propelling the market growth. Moreover, the rapid outbreak of COVID-19 is acting as another significant factor, necessitating increased hospitalization rates and further escalating the need for intravenous solutions. Besides this, advancements in healthcare infrastructure, coupled with the governments' commitments to improving healthcare standards and services, are leading to a larger adoption of these solutions. Concurrently, an increase in the number of surgical procedures is also contributing to the market growth. In line with this, these surgeries require the administration of anesthesia and post-operative care often involving the use of intravenous solutions. Furthermore, the increased expenditure on healthcare, spurred by high per capita income in the region, is also a major driving force. Continuous advancements in intravenous solutions technology, including improvements in solution composition and delivery methods, are propelling the market forward. This constant technological progression is encouraging adoption, thereby creating a positive outlook for the market across the region. Looking forward, IMARC Group expects the market to reach US$ 997.8 Million by 2028, expanding at a growth rate (CAGR) of 5.9% during 2023-2028.
- Based on the type, the market is segmented into partial parenteral nutrition and total parenteral nutrition. Currently, total parenteral nutrition is dominating the market.
- Based on the nutrients, the market is divided into carbohydrates, salts and electrolytes, minerals, vitamins, and amino acids. Presently, amino acids hold the largest market share.
- Based on the country, the market is divided into Saudi Arabia, the United Arab Emirates (UAE), Qatar, Oman, Kuwait, and Bahrain. Currently, Saudi Arabia is holding the largest market share.
- The competitive landscape of the industry has also been examined along with the profiles of the key players.
|Base Year of the Analysis
||Type, Nutrients, Country
||Saudi Arabia, UAE, Qatar, Oman, Kuwait, Bahrain
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800